AAAAAA

   
Results: 1-11 |
Results: 11

Authors: SPANIK S STUDENA M SYKORA J KUNOVA A TRUPL J PICHNA P DEMITROVICOVA A KRALOVICOVA K GREY E KUKUCKOVA E KOREN P KRCMERY V
Citation: S. Spanik et al., IMPACT OF OFLOXACIN USED PROPHYLACTICALLY IN NEUTROPENIC PATIENTS ON DEVELOPMENT OF RESISTANCE, Infectious diseases in clinical practice, 7(4), 1998, pp. 199-202

Authors: SPANIK S SUFLIARSKY J MARDIAK J SORKOVSKA D TRUPL J KUNOVA A KUKUCKOVA E RUSNAKOVA V DEMITROVICOVA A PICHNA P KRUPOVA I KRALOVICOVA K MATEICKA F WEST D KRCMERY V
Citation: S. Spanik et al., PREDICTORS OF MORTALITY IN BACTEREMIC CANCER-PATIENTS - RETROSPECTIVEANALYSIS OF 64 DEATHS OCCURRING AMONG 262 BACTEREMIC EPISODES, Supportive care in cancer, 6(3), 1998, pp. 291-294

Authors: KRCMERY V ORAVCOVA E SPANIK S MRAZOVASTUDENA M TRUPL J KUNOVA A STOPKOVAGREY K KUKUCKOVA E KRUPOVA I DEMITROVICOVA A KRALOVICOVA K
Citation: V. Krcmery et al., NOSOCOMIAL BREAKTHROUGH FUNGEMIA DURING ANTIFUNGAL PROPHYLAXIS OR EMPIRICAL ANTIFUNGAL THERAPY IN 41 CANCER-PATIENTS RECEIVING ANTINEOPLASTIC CHEMOTHERAPY - ANALYSIS OF ETIOLOGY RISK-FACTORS AND OUTCOME, Journal of antimicrobial chemotherapy, 41(3), 1998, pp. 373-380

Authors: NOVOTNY J KRALOVICOVA K KREMERY V SPANIK S HALKO J NETRIOVA J STUDENAMRAZOVA M GRAUSOVA S KOREN P KRUPOVA Y DEMITROVICOVA A KUKUCKOVA E
Citation: J. Novotny et al., IS ROUTINE DRUG-MONITORING OF VANCOMYCIN SERUM LEVELS NEEDED, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4714-4714

Authors: KRALOVICOVA K SPANIK S HALKO J NETRIOVA J STUDENAMRAZOVA M NOVOTNY J GRAUSOVA S KOREN P KRUPOVA I DEMITROVICOVA A KUKUCKOVA E KRCMERY V
Citation: K. Kralovicova et al., DO VANCOMYCIN SERUM LEVELS PREDICT FAILURES OF VANCOMYCIN THERAPY OR NEPHROTOXICITY IN CANCER-PATIENTS, Journal of chemotherapy, 9(6), 1997, pp. 420-426

Authors: KRCMERY V SPANIK S STOPKOVA K GRAUSOVA S MARDIAK J KOREN P SEPESI J PECHAN J DEMITROVICOVA A KRALOVICOVA K NOVOTNY J
Citation: V. Krcmery et al., BACTEREMIA IN CANCER-PATIENTS WITH SOLID TUMORS UNDERGOING CHEMOTHERAPY VERSUS SURGERY - RISK-FACTORS, ETIOLOGY AND OUTCOME IN 276 PATIENTS, Journal of chemotherapy, 9(3), 1997, pp. 232-237

Authors: KUNOVA A TRUPL J DEMITROVICOVA A JESENSKA Z GRAUSOVA S GREY E PICHNA P KRALOVICOVA K SORKOVSKA D KRUPOVA I SPANIK S STUDENA M KOREN P KRCMERY V
Citation: A. Kunova et al., 8-YEAR SURVEILLANCE OF NON-ALBICANS CANDIDA SPP IN AN ONCOLOGY-DEPARTMENT PRIOR TO AND AFTER FLUCONAZOLE HAD BEEN INTRODUCED INTO ANTIFUNGAL PROPHYLAXIS, Microbial drug resistance, 3(3), 1997, pp. 283-287

Authors: SPANIK S KUKUCKOVA E PICHNA P GRAUSOVA S KRUPOVA I RUSNAKOVA V KRALOVICOVA K KRCHNAKOVA A MRAZOVA M LACKA J KOREN P STOPKOVA K NOGOVA J DEMITROVICOVA A HELPIANSKA L KREMERY V
Citation: S. Spanik et al., ANALYSIS OF 553 EPISODES OF MONOMICROBIAL BACTEREMIA IN CANCER-PATIENTS - ANY ASSOCIATION BETWEEN RISK-FACTORS ACID OUTCOME TO PARTICULAR PATHOGEN, Supportive care in cancer, 5(4), 1997, pp. 330-333

Authors: KCMERY V HALKO J KRALOVICOVA K GRAUSOVA S STOPKOVA K NETRIOVA J
Citation: V. Kcmery et al., NETILMICIN SERUM LEVELS IN 138 CANCER-PATIENTS - DO THEY PREDICT NEPHROTOXICITY OR THERAPEUTIC FAILURE, International journal of antimicrobial agents, 8(3), 1997, pp. 215-216

Authors: TRUPL J KUNOVA A ORAVCOVA E PICHNA P KUKUCKOVA E GRAUSOVA S GREY E SPANIK S DEMITROVICOVA A KRALOVICOVA K LACKA J KRUPOVA I SVEC J KOREN P KRCMERY V
Citation: J. Trupl et al., RESISTANCE PATTERN OF 2,816 ISOLATES ISOLATED FROM 17,631 BLOOD CULTURES AND ETIOLOGY OF BACTEREMIA AND FUNGEMIA IN A SINGLE CANCER INSTITUTION, Acta oncologica, 36(6), 1997, pp. 643-649

Authors: KRALOVICOVA K SPANIK S ORAVCOVA E MRAZOVA M MOROVA E GULIKOVA V KUKUCKOVA E KOREN P PICHNA P NOGOVA J KUNOVA A TRUPL J KRCMERY V
Citation: K. Kralovicova et al., FUNGEMIA IN CANCER-PATIENTS UNDERGOING CHEMOTHERAPY VERSUS SURGERY - RISK-FACTORS, ETIOLOGY AND OUTCOME, Scandinavian journal of infectious diseases, 29(3), 1997, pp. 301-304
Risultati: 1-11 |